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Inositol 1,4,5-trisphosphate (IP3) receptors are calcium-releasing channels localized on the sarcoplasmic reticulum. IP3 receptors mediate the
calcium mobilizing effect of a wide range of hormones, cytokines, and neurotransmitters and play an important role in variety of cell functions.
The aim of this work was to study, how partial depletion of catecholamines affects the gene expression and protein levels of the type 1 IP3
receptors in rat heart. The type 1 IP3 receptor mRNA levels were studied in the left cardiac atrium and ventricle of rats treated with 6-
hydroxydopamine (6-OHDA) in control and stressed conditions. The 6-OHDA produces anatomical and functional denervation resulting in
decreased levels of noradrenaline and adrenaline. We also used corticoliberin (CRH) knockout mice, where secretion of adrenaline is significantly
suppressed. Administration of 6-OHDA significantly decreases mRNA levels of the type 1 IP3 receptor in both, the left atrium and the left
ventricle, while the gene expression of the sarcoplasmic reticular Ca2+-ATPase (SERCA 2) was unaffected. CRH knockout mice possess markedly
lower levels of the type 1 IP3 receptor mRNA compared to wild-type mice in both, control and stressed conditions. These data point to the
adrenergic modulation of the type 1 IP3 receptors in the rat hearts.
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The inositol 1,4,5-trisphosphate receptors (IP3 receptors) are
intracellular membrane channels essential for calcium release
from intracellular stores. Physiological function of IP3 recep-
tors in the heart is not completely understood yet. Compared to
ryanodine receptors, responses to IP3 are slow and weak, and
the calcium so generated does not contribute to calcium-
induced calcium release. Thus, IP3 is less likely to be important
in regulating beat-to-beat changes in intracellular calcium
under physiological conditions. All three types of IP3 receptors
(types 1, 2 and 3) are expressed in the heart. Type 2 IP3
receptor is most abundant in cardiomyocytes, while type 1
occurs predominantly in cardiac ganglia [1]. The neurons of
these ganglia, situated at the outer surface of the atria, receive
input from efferent vagal fibres and they innervate the atrial0167-4889/$ - see front matter D 2005 Elsevier B.V. All rights reserved.
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nodes, thus playing a crucial role in the regulation of heart rate
[2,3]. Type 1 IP3 receptors might be involved in the activation
of neurons in cardiac parasympathetic ganglia by sympathetic
stimulation and therefore adrenergic modulation of these
receptors might be important in this process. Modulation of
IP3 receptors during some cardiac diseases was also proposed.
IP3 receptors mediate the calcium mobilizing effect of a wide
range of hormones, cytokines and neurotransmitters (for review
see [4]). Among them, catecholamines acting through the a-
and h-adrenergic receptors play an unmistakable role in the
cardiac function. Stimulation of the a1 adrenergic receptors
(a1AR; which are abundant in myocardium) results in the
activation of phospholipase C and production of the IP3. In
addition, a1AR activation induces transcriptional activation of
early- and late-response genes [5]. In several species a1AR
density is higher in the ventricular than in atrial tissues [6]. The
heart expresses also h1 and h2AR; both subtypes increase
cardiac frequency and contractility [7]. The hAR system
activates adenylyl cyclases and thereby elevates cAMP.ta 1763 (2006) 18 – 24
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stimulates also phospholamban [7]. Phospholamban is an
inhibitor of sarcoplasmic reticular Ca2+-ATPase (SERCA)
and both these proteins can affect IP3 receptors through the
loading of calcium stores. Therefore, catecholamines can affect
the IP3 receptors by several mechanisms.
6-hydroxydopamine (6-OHDA) is neurotoxin that destroys
catecholaminergic terminals [8]. Administration of 6-OHDA to
rats produces anatomical and functional noradrenergic dener-
vation and induces compensatory hyperreactivity of the
suprarenal chromaffin cells. These effects are manifested by
the increase in the activity of catecholamine synthesizing
enzymes [9]. In the rat heart, a significant increase in the
phenylethanolamine-N-methyltransferase (PNMT) activity was
found in 6-OHDA-treated rats, compared to controls [10].
Corticotropin-releasing hormone (corticoliberin; CRH) is
thought to be important for the function of the adrenomedullary
catecholaminergic system. Thus, CRH knockout mice repre-
sent a good experimental model to study regulatory pathways
and physiological importance of the altered hypothalamic–
pituitary–adrenocortical (HPA) axis, and also stress response
in mammals (for review see [11]). CRH deficiency leads to
impaired gene expression and catecholaminergic enzyme
activity levels, and to weakened adrenaline synthesis and
secretion in the adrenal medulla, possibly due to impaired
adrenocortical corticosterone production [12]. CRH knockout
(CRH KO) mice exhibit also blunted glucocorticoid assembly.
It is therefore possible that the adrenal medulla could contribute
to the elevation of plasma noradrenaline [12].
Stress is one of major contributors to the development of
cardiovascular diseases and psychiatric illnesses. Therefore, it
is crucial to clarify mechanisms involved in the conversion of
brief beneficial responses to stressors into prolonged detrimen-
tal consequences. We have already shown different effect of
single and repeated immobilization stress on gene expression
of the IP3 receptors. After the single immobilization stress, the
gene expression of the type 1 IP3 receptors was increased [13],
while after the repeated immobilization stress for seven times,
both gene expression and protein of the type 1 IP3 receptors
were decreased significantly in the left atrium of rats [14].
In this work we focused on the effect of chemical
sympathectomy by 6-OHDA on the type 1 IP3 receptors. The
aim of this work was to study, how partial depletion of
catecholamines can affect the gene expression and protein
levels of the type 1 IP3 receptors in the rat heart.Table 1
Sequences of primers, their position and product size
Primer Primer sequences
IP3R1A 5V-GTG GAG GTT TCA TCT GCA AGC-3V
IP3R1B 5V-GCT TTC GTG GAA TAC TCG GTC-3V
SERCA2A 5V-ATT GTT CGA AGT CTG CCT TCT GTG G
SERCA2B 5V-CAT AGG TTG ATC CAG TTA TGG TAA A
PLB-A 5V-GAA CCT CCA GAA CCT CTT TAT CAA T
PLB-B 5V-TGA CCC TTC ACG ACG ATG TCC CAG C
GAPDH1 5V-AGA TCC ACA ACG GAT ACA TT-3V
GAPDH2 5V-TCC CTC AAG ATT GTC AGC AA-3V
(IP3R1) type 1 IP3 receptor, (SERCA2) sarco(endo)plasmic reticulum Ca
2+-ATPase,2. Material and methods
2.1. Animals
The Ethic Committee of the Institute of Experimental Endocrinology,
Slovak Academy of Sciences approved all presented experiments.
Male Sprague–Dawley rats (cca 350 g, Charles River, Suzfeld, Germany) 4
months old were used for 6-OHDA experiment. Prior to experiments, animals
were housed for 1 week, four animals per cage in a controlled environment
(22T2 -C, 12 h light/dark cycle, light on at 6.00 a.m.). Food and water were
available ad libitum. One experimental group of rats was treated two times
(second administration after 24 h) by 6-OHDA, each dose was 100 mg per 1 kg
of body weight. Sham vehicle-treated and 6-OHDA-treated animals were
divided into 2 groups and one control group and one 6-OHDA group of rats
was immobilized once for 2 h as described previously [15] and decapitated 3
h after the IMO termination. Each group was composed of 10 animals. Animals
were sacrificed by decapitation 2 weeks after the last 6-OHDA administration;
left ventricle and atrium was withdrawn and immediately frozen in the liquid
nitrogen.
CRH KO mouse line was originally obtained from the Harvard Medical
School, Department of Endocrinology, Boston, USA [16]. Presence of CRH
KO allele was specified by using tail DNA isolation with subsequent PCR.
Male CRH knockout mice approximately 12 weeks old were used in this
experimental study. The presence of CRH KO allele was specified using tail
DNA isolation with subsequent PCR [14,17]. Mice were maintained under
controlled environmental conditions (22T1 -C, 12-h light/dark cycle, lights on
at 6:00 A.M.). Immobilization stress was performed as described previously
[15], however, the size of immobilization boards was modified for mice.
Repeated stress was achieved by immobilizing the animals for 7 days, 2 h daily
with subsequent decapitation 3 h after the last, seventh immobilization (7).
Control mice were sacrificed immediately after removal from their home cages.
2.2. RNA isolation and relative quantification of mRNA levels by
reverse transcription and subsequent polymerase chain reaction
(RT-PCR)
Population of total RNAs was isolated by TRI Reagent (MRC Ltd.).
Briefly, tissue samples were homogenized by tissue homogenizer (Biospec
Products Inc.) in TRI Reagent and after 5 min the homogenate was extracted by
chloroform. RNAs in the aqueous phase were precipitated by isopropanol.
RNA pellet was washed with 75% ethanol and stored under 96% ethanol at
70 -C. The purity and integrity of isolated RNAs was checked on GeneQuant
Pro spectrophotometer (Amersham Biosciences). Reverse transcription was
performed using 1.5 Ag of total RNAs and Ready-To-Go You-Prime First-
Strand Beads (Amersham Biosciences) with pd(N6) primer. PCR specific for
the type 1 IP3 receptor (IP3R1) was carried out afterwards using primers (Table
1; GI: 1055286) described in Genazzani et al. [18]. Sarco(endo)plasmic
reticulum Ca2+-ATPase (SERCA2; GI: 8392934) gene and Phospholamban
(PLB; GI: 313809) gene were amplified with primer sets according to Seth et
al. [19]. Glyceraldehyde 3-phosphate dehydrogenase (GAPDH; [20]) expres-
sion was used as a housekeeper gene control for semi-quantitative evaluation of
PCR. All used primer sequences, together with corresponding position and
fragment size for each amplified gene, are listed in Table 1. Each PCR programPosition Product size (bp)
70–90
456–476 410
-3V 1489–1522
-3V 1648–1672 174
-3V 251–276
-3V 426–450 199
795–814
506–525 309
(PLB) phospholamban, (GAPDH) glyceraldehyde 3-phosphate dehydrogenase.
Fig. 1. Noradrenaline (A) and adrenaline (B) levels in the left ventricle of sham-
(fine striped columns) and 6-OHDA- (coarse striped columns) treated rats. Both
tissue noradrenaline and adrenaline were depressed in 6-OHDA-treated animals
in control conditions and also after the single exposure to immobilization stress
(IMO). Results are presented as a meanTS.E.M. Statistical differences among
groups were determined by one-way analysis of variance (ANOVA). Statistical
significance between sham-treated and 6-OHDA-treated rats was considered as
**P <0.01 and ***P <0.001. Statistical significance between control and
immobilized group of rats was defined as ##P <0.01.
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2 and PLB), 30 (for GAPDH) or 35 (for IP3R1) cycles of denaturation at 94 -C
for 1 min, annealing at 60 -C for 1 min, and polymerization at 72 -C for 1 min.
PCRs were terminated by final polymerization at 72 -C for 7 min. All PCR
products were analyzed on 2% agarose gels. Optical density (od/mm2) of
individual bands was measured by Kodak camera and Biometra software.
2.3. Western blot analysis
The IP3R1 protein was determined in crude membrane fraction from the left
ventricle by Western blot analysis. Protein concentration was determined
according to Lowry et al. [21]. 100 Ag of protein extract from cardiac atria and
ventricles were used for Western blot analysis, as described in Zacikova et al.
[22]. Using a polyclonal antiserum specific for IP3R1 receptor we detected
immunoreactive protein of approximately 240 kDa. Specific anti-IP3-receptor
polyclonal antibody (rabbit, dilution 1:1000 in 5% non-fat dry milk; Abcam)
was raised against a synthetic peptide corresponding to the C-terminus of
human IP3 receptor (amino acids 1829–1848). This sequence is 100%
conserved in human, mouse, and rat type 1 IP3 receptor protein. Antibody
cross-reacts with dog and rat and is expected to cross-react with human and
mouse due to sequence homology (100%). After the incubation with secondary
anti-rabbit antibody conjugated to the horseradish peroxidase (1:5000),
immunoreactive proteins were visualized by ECL detection system (Amersham
Biosciences). As a control of equal loading, levels of GAPDH were determined
with mouse anti GAPDH monoclonal antibody (dilution 1:500; Chemicon).
2.4. Statistical analysis
Each value represents the average for 5-10 animals. Results are presented as
meansTS.E.M. Statistical differences among groups were determined by one-
way analysis of variance (ANOVA). Statistical significance P <0.05 was
considered to be significant. For multiple comparisons, an adjusted t test with
P values corrected by the Bonferroni method was used (Instat, GraphPad
Ssoftware, USA).
3. Results
Treatment with the 6-OHDA decreased significantly levels
of the heart noradrenaline in both, control (from 123T32 to
44T12 Ag/g tissue) and immobilized (from 122T25 to 43T6
Ag/g tissue) group (Fig. 1A). Tissue adrenaline was also
decreased by 6-OHDA treatment (from 7.0T3.1 to 2.8T1.0
Ag/g tissue; Fig. 1B). In the group of sham-treated rats,
concentration of tissue adrenaline was significantly elevated
by single immobilization (from 7.0T3.1 to 19.7T3.6 Ag/g
tissue), but immobilization-induced increase in adrenaline
levels in 6-OHDA-treated rats was highly suppressed (from
19.7T3.6 to 5.9T1.0 Ag/g tissue). The type 1 IP3 receptor
mRNA levels in left atria and left ventriculi of rat
myocardium revealed significant differences between control
animals and animals treated with the 6-OHDA (Fig. 2). In left
atria administration of the 6-OHDA significantly decreased
IP3 receptors of type 1 mRNA levels in both, control (from
44.8T2.3 to 26.6T2.3 a.u.) and one time immobilized group
of rats (from 47.7T3.1 to 30.2T1.8 a.u.; Fig. 2A). In the left
ventriculi, similar decrease in IP3R1 mRNA (Fig. 2B) and
protein (Fig. 2C) levels was observed. Control IP3R1 mRNA
levels decreased (from 77.8T2.1 to 41.3T5.3 a.u.) and IP3R1
gene expression of immobilized animals was lowered (from
103.9T11 to 73.9T9.8 a.u.) in 6-OHDA-treated group of rats,
compared to sham-treated rats. The type 1 IP3R1 protein was
also lower after 6-OHDA treatment in both, control (from786T39 to 369T168 a.u.) and immobilized (from 1108T144
to 686T62 a.u.) group. Nevertheless, 6-OHDA treatment did
not alter levels of the SERCA and phospholamban (Table 2)
in the left atria/ventriculi, neither in control conditions, nor
after the stress exposure.
CRH knockout mice manifested slightly increased levels of
plasma noradrenaline compared to wild-type mice (from
6189T608 to 8396T1049 pg/ml; Fig. 3A), but rapid decrease
in plasma adrenaline (from 6318T1131 to 2277T231 pg/ml;
Fig. 3B) has been observed. In the left atrium of CRH KO
mice, the gene expression of type 1 IP3 receptor was
significantly lower than in left atrium of wild-type animals
(19.2T3.0 vs. 6.1T1.1 a.u.; Fig. 4A). After the repeated
immobilization for 7-times levels of the IP3R1 mRNA
significantly decreased in wild-type group of mice compared
to control (from 19.2T3.0 to 6.9T1.1 a.u.), while in CRH KO
Fig. 2. The IP3R1 mRNA levels in the left atrium (A), the left ventricle (B) and left ventricular protein levels (C) of sham- (fine striped columns) and 6-OHDA-
(coarse striped columns) treated rats. In the upper part, representative results of IP3R1 and GAPDH from gels are shown. The mRNA levels of the IP3R1 were
decreased in both, left atrium and left ventricle of control and also single immobilized (IMO) rats. Also IP3R1 protein was decreased after 6-OHDA treatment.
Results are presented as meanTS.E.M. Statistical differences among groups were determined by one-way analysis of variance (ANOVA). Statistical significance
between sham-treated and 6-OHDA-treated rats was determined as *P <0.05, **P <0.01 and ***P <0.001.
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sion of the IP3R1 at all (from 6.1T1.1 to 6.4T1.4 a.u.).
Similarly, in the left ventricles CRH knockouts expressed
IP3R1 mRNA in significantly lower levels than their wild-type
counterparts (Fig. 4B; wt: 19.2T0.9 a.u. vs. CRH KO: 8.1T1.0
a.u.). Repeated immobilization for 7-times significantly de-
creased IP3R1 gene expression in wild-type animals compared
to their controls (from 19.2T0.9 a.u. to 6.4T0.6 a.u.). Decrease
of the gene expression of the type 1 IP3 receptor due to 7- times
repeated immobilization was observed also in the CRH KO
group of mice (from 8.1T1.0 a.u. to 4.6T0.8 a.u.).
4. Discussion
In this paper, we demonstrate that partial depletion of
catecholamines decreased significantly mRNA and protein
levels of the type 1 IP3 receptors in the heart in both, control
conditions and after the exposure to immobilization stress for
two h. Interestingly, mRNA levels of phospholamban and
SERCA 2, responsible for calcium loading of the intracellular
stores were unaffected by catecholamine depletion.
In cardiac muscle, several plasma membrane receptors
(a1AR, muscarinic, angiotensin II, endothelin, etc.) areTable 2
SERCA 2 and phospholamban mRNA levels in the left atrium (LA) and the left
ventricle (LV)
mRNA (a.u.) Control 6-OHDA Control IMO 6-OHDA IMO
SERCA 2 LA 887T227 884T100 900T230 888T85
SERCA2 LV 538T71 544T104 512T23 585T64
Phospholamban LV 136T11 139T9 145T5 140T4coupled to phosphatidylinositol 4,5-bisphosphate (PIP2) turn-
over [23–26]. PIP2 is cleaved by phospholipase C and
produces IP3 and diacylglycerol. The IP3 activates IP3
receptors. The mRNA encoding the intracellular IP3 receptor
has been detected in the heart [13,27,28]. However, the
physiological role of calcium release through the IP3 receptors
in the heart remains elusive. Nevertheless, in Purkinje
myocytes, IP3-induced calcium release appears to be causally
related to both increase in automaticity and generation of some
arrhythmias after a1-adrenergic stimulation [26].
Catecholamines are distinguished modulators of the cardiac
function, because of their strong inotropic and chronotropic
effect. Rapacciuolo and coworkers [29] clearly established the
important role of noradrenaline and adrenaline in the induction
of cardiac hypertrophy and suggested that blocking the action
of adrenaline and noradrenaline would not only be favorable
with regard to cell survival, but it would also inhibit cardiac
hypertrophy. 6-OHDA is a potent neurotoxin used extensively
to produce chemical sympathectomy in experimental animals
and an important tool for the understanding of the adrenergic
mechanism [9,30,31]. In accordance with other laboratories
[9,10,32], we observed depletion of noradrenaline levels in 6-
OHDA-treated rats compared to controls. Adrenaline levels
were also decreased, since noradrenaline is a substrate for
adrenaline production. 6-OHDA treatment of rats results in the
suppression of the gene expression and protein levels of the
type 1 IP3 receptors both in the left atrium and left ventricle.
Mechanism, by which chemical sympathectomy by 6-OHDA
reduces the level of IP3R1, is not clear. Several suggestions
about the possible mechanism of this effect should be taken in
the consideration. Firstly, since the type 1 IP3 receptor is
Fig. 3. Plasma noradrenaline (A) and adrenaline (B) levels in wild-type and CRH KO mice. Plasma noradrenaline was not significantly changed, although the
tendency of increase was observed in CRH KO mice compared to wild-type controls. Plasma adrenaline was significantly depressed in CRH KO animals. Results are
presented as a meanTS.E.M. Statistical differences among groups were determined by one-way analysis of variance (ANOVA). Statistical significance was defined
as **P <0.01.
Fig. 4. The type 1 IP3 receptor mRNA levels in the left atrium (A) and the lef
ventricle (B) of wild-type (empty columns) and CRH KO (striped columns
mice. The mRNA levels of the IP3R1 were decreased significantly in both, lef
atrium and left ventricle of CRH KO mice compared to wild-type mice
Repeated immobilization stress decreased significantly mRNA levels of the
IP3R1 in both, left atrium and left ventricle (empty columns). After the repeated
immobilization for seven times, no significant difference was observed among
wild-type and CRH KO mice in both, left atrium and the left ventricle. Results
are presented as meanTS.E.M. Statistical differences among groups were
determined by one-way analysis of variance (ANOVA). Statistical significance
between wild-type (WT) control and CRH KO control group was defined as
***P <0.001 and between WT control and IMO control was defined as
###P <0.001.
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sympathectomy can affect IP3 receptors in neuronal cells as
well, which might result in downregulation of their gene
expression. Also, it was previously reported that different gene
expression profiles in cardiomyocytes were observed after
noradrenaline infusion [32,33]. Golden et al. [34] reported that
noradrenaline treatment alters DHPR mRNA and protein
levels, possibly through the AP1 transcription factor. Since
type 1 IP3 receptor promoter has two AP1 transcription factors
[35], we might speculate that chemical sympathectomy, which
results in depletion of noradrenaline levels affects these
receptors also through the AP1 transcription factors. Never-
theless, this proposal remains to be experimentally verified.
We also tested the hypothesis, whether mRNA levels of
SERCA2 are also modified. We have found that gene
expression of the SERCA2 and phospholamban was not
altered due to 6-OHDA treatment. Ishibashi and coworkers
[36] showed that noradrenaline increased intracellular calcium
even in the absence of extracellular calcium. Depletion of
calcium stores has been reported to activate the cation channels
[37,38]. Thus, activation of cation channels of rat cardiac
ganglion neurons depends on calcium released from calcium
stores via IP3 receptors, but not on the depletion of the calcium
store per se [36]. Depleted noradrenaline would probably
decrease demands for intracellular calcium released through the
type 1 IP3 receptors, which in turn results in the decreased gene
expression of these intracellular calcium channels.
Cardiac h-adrenergic receptors, which respond to neuron-
ally released and circulating catecholamines, are important
regulators of cardiac function. h-AR mediated stimulation of
adenylyl cyclase increases cellular levels of cAMP and, in turn,
the phosphorylation via cAMP dependent protein kinase of
proteins such as phospholamban, calcium channels, and
contractile proteins. Phosphorylation of these proteins alters
their activity and leads to a functional response [39]. The
phosphorylation of IP3 receptors mediated by cAMP dependentt
)
t
.
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has been proposed as an explanation for the diverse abilities of
distinct G-protein-coupled receptors that signal through the IP3
receptors to initiate and/or sustain intracellular calcium
oscillations [40]. Impaired activation of hAR signaling results
into a reduction of the amount of cAMP, which in turns binds
to the regulatory subunits of PKA and phosphorylation of a
number of protein targets can be rendered. Thus, decreased
levels of adrenaline in our experiments can reduce gene
expression of the IP3 receptors also via hAR.
Prolonged stress is one of the major contributors to the
development of several diseases, such as psychiatric illnesses
or those of cardiovascular origin. Immobilization stress is one
of the most potent stressors, since it activates both pathways of
the sympathoadrenal system. Single exposure to the immobi-
lization stress affects the gene expression and thus the protein
levels of IP3 receptors differently in various tissues [13,41,42].
Repeated immobilization decreased a gene expression of the
type 1 and 2 IP3 receptors and also protein levels of the IP3
receptors in the rat heart [14]. In the hearts of wild-type mice
we observed the same decrease in gene expression of the type 1
IP3 receptors as we published in Krepsova et al. [14] in rats.
Modulatory effect of immobilization stress on the type 1 IP3
receptors might be part of the compensatory mechanism, by
which heart respond to the development of the pathophysio-
logical state. Nevertheless, this proposal remains to be verified.
Many stressors increase the secretion of catecholamines
from the adrenal medulla and sympathetic nerve terminals.
Such stressors also potentiate the secretion of the hypothalam-
ic–pituitary–adrenocortical (HPA) axis hormones, glucocorti-
coids from the adrenal cortex via stimulation by the
hypothalamic neuropeptide, CRH [43]. CRH contributes to
the regulation of the adrenomedullary catecholaminergic
system under stressful conditions through both the HPA axis
and sympathetic nervous system. CRH deficiency leads to
impaired PNMT gene expression and enzyme activity levels,
and to impaired adrenaline synthesis and secretion in the
adrenal medulla [12]. We also observed significantly depressed
levels of plasma adrenaline in CRH KO mice compared to
wild-type mice, although the levels of noradrenaline were
slightly increased. Since CRH KO mice exhibit blunted
glucocorticoid production, some fractions of the elevated
plasma noradrenaline may arise from secretion by nerve
terminals of the sympathetic nervous system. It is also possible
that the adrenal medulla could contribute to elevation of plasma
noradrenaline because the accumulation of adrenal noradren-
aline might occur due to chronically impaired conversion of
noradrenaline to adrenaline in CRH KO mice [12]. In the hearts
of CRH KO mice, levels of the type 1 IP3 receptor mRNAwere
also lower compared to their wild-type mates. After repeated
immobilization stress for 7 days, levels of the type 1 IP3
receptor mRNA decreased significantly [14], while levels of
immobilized CRH KO mice remained the same as in CRH KO
controls. This observation might suggest that glucocorticoid
and/or adrenergic regulation is involved in this process.
In summary, we have found that the type 1 IP3 receptors are
downregulated when catecholamines are partially depleted.This effect can be realized through the a1AR and/or hAR. The
present findings provide a molecular basis for the hypothesis
that mechanism of the adrenergic modulation in the heart
involves the type 1 IP3 receptors.
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